STAT: cAMP-PKA-signal transducers and activators of transcription
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Substudy: Loomba R, Hartman ML, Lawitz EJ, et al
April 1, 2026: More Lawsuits Join Vision Loss MDL for GLP-1 Drugs, Like Ozempic As of April 1, 2026, there are 73 pending lawsuits in the centralized litigation for people alleging NAION from GLP-1 drugs, including Ozempic
Kaku, K., Rasmussen, M
Early trials suggest these might produce even greater weight loss, potentially approaching 30% or more
Winner: Supergut The Science Supergut: The science behind Supergut's approach has been conducted on the individual ingredients in the proprietary resistant starch blend: prebiotic fiber feeds gut bacteria, gut bacteria produce short-chain fatty acids, short-chain fatty acids stimulate GLP-1 release